TY - JOUR
T1 - Inflammatory and regenerative processes in bioresorbable synthetic pulmonary valves up to two years in sheep: Spatiotemporal insights augmented by Raman microspectroscopy
AU - de Kort, Bente J.
AU - Marzi, Julia
AU - Brauchle, Eva
AU - Lichauco, Arturo
AU - Bauer, Hannah
AU - Serrero, Aurelie
AU - Dekker, Sylvia
AU - Cox, Martijn A.J.
AU - Schoen, Fred
AU - Schenke-Layland, Katja
AU - Bouten, Carlijn V.C.
AU - Smits, Anthal I.P.M.
PY - 2021/11
Y1 - 2021/11
N2 - In situ heart valve tissue engineering is an emerging approach in which resorbable, off-the-shelf available scaffolds are used to induce endogenous heart valve restoration. Such scaffolds are designed to recruit endogenous cells in vivo, which subsequently resorb polymer and produce and remodel new valvular tissue in situ. Recently, preclinical studies using electrospun supramolecular elastomeric valvular grafts have shown that this approach enables in situ regeneration of pulmonary valves with long-term functionality in vivo. However, the evolution and mechanisms of inflammation, polymer absorption and tissue regeneration are largely unknown, and adverse valve remodeling and intra- and inter-valvular variability have been reported. Therefore, the goal of the present study was to gain a mechanistic understanding of the in vivo regenerative processes by combining routine histology and immunohistochemistry, using a comprehensive sheep-specific antibody panel, with Raman microspectroscopy for the spatiotemporal analysis of in situ tissue-engineered pulmonary valves with follow-up to 24 months from a previous preclinical study in sheep. The analyses revealed a strong spatial heterogeneity in the influx of inflammatory cells, graft resorption, and foreign body giant cells. Collagen maturation occurred predominantly between 6 and 12 months after implantation, which was accompanied by a progressive switch to a more quiescent phenotype of infiltrating cells with properties of valvular interstitial cells. Variability among specimens in the extent of tissue remodeling was observed for follow-up times after 6 months. Taken together, these findings advance the understanding of key events and mechanisms in material-driven in situ heart valve tissue engineering.
AB - In situ heart valve tissue engineering is an emerging approach in which resorbable, off-the-shelf available scaffolds are used to induce endogenous heart valve restoration. Such scaffolds are designed to recruit endogenous cells in vivo, which subsequently resorb polymer and produce and remodel new valvular tissue in situ. Recently, preclinical studies using electrospun supramolecular elastomeric valvular grafts have shown that this approach enables in situ regeneration of pulmonary valves with long-term functionality in vivo. However, the evolution and mechanisms of inflammation, polymer absorption and tissue regeneration are largely unknown, and adverse valve remodeling and intra- and inter-valvular variability have been reported. Therefore, the goal of the present study was to gain a mechanistic understanding of the in vivo regenerative processes by combining routine histology and immunohistochemistry, using a comprehensive sheep-specific antibody panel, with Raman microspectroscopy for the spatiotemporal analysis of in situ tissue-engineered pulmonary valves with follow-up to 24 months from a previous preclinical study in sheep. The analyses revealed a strong spatial heterogeneity in the influx of inflammatory cells, graft resorption, and foreign body giant cells. Collagen maturation occurred predominantly between 6 and 12 months after implantation, which was accompanied by a progressive switch to a more quiescent phenotype of infiltrating cells with properties of valvular interstitial cells. Variability among specimens in the extent of tissue remodeling was observed for follow-up times after 6 months. Taken together, these findings advance the understanding of key events and mechanisms in material-driven in situ heart valve tissue engineering.
KW - Biomaterial
KW - Endogenous tissue restoration
KW - Foreign body response
KW - Guided tissue regeneration
KW - In situ tissue engineering
KW - Tissue-engineered heart valve (TEHV)
UR - http://www.scopus.com/inward/record.url?scp=85115918469&partnerID=8YFLogxK
U2 - 10.1016/j.actbio.2021.09.005
DO - 10.1016/j.actbio.2021.09.005
M3 - Article
C2 - 34509697
SN - 1742-7061
VL - 135
SP - 243
EP - 259
JO - Acta Biomaterialia
JF - Acta Biomaterialia
ER -